{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/endomorphin-1/vermont/","compound":{"slug":"endomorphin_1","name":"Endomorphin-1","same_as":"https://en.wikipedia.org/wiki/Endomorphin"},"jurisdiction":{"code":"VT","name":"Vermont"},"as_of":"2026-07-18","answer":"As of July 18, 2026, Endomorphin-1 is legal to sell at retail in Vermont. Unscheduled - legal as research-use-only; no operative instrument reaches a structurally-dissimilar opioid peptide. Controlling source: 18 V.S.A. 4201(16) (narcotic def).","forms":[{"form":"all","label":"All forms","status":"legal","state_status":null,"federal_overlay":false,"headline":"Unscheduled - legal as research-use-only; no operative instrument reaches a structurally-dissimilar opioid peptide","rule_type":"permanent","tier":"unscheduled","schedule_class":null,"limit":null,"effective_date":null,"verified_at":"2026-07-18","confidence":"confirmed","verbatim_excerpt":"18 V.S.A. 4201 contains no statutory analogue definition or offense. 4201(16): a \"narcotic\" is an opiate plus substances \"neither chemically nor physically distinguishable\" from a listed narcotic, as designated by Department of Health rule. A novel tetrapeptide is neither. [No analogue statute; rule-designated narcotic scheme.]","excerpt_source_url":"https://legislature.vermont.gov/statutes/section/18/084/04201","citations":[{"title":"18 V.S.A. 4201(16) (narcotic def)","url":"https://legislature.vermont.gov/statutes/section/18/084/04201","pinpoint":null,"publisher":"Vermont Legislature","type":"statute","primary":true,"official":true},{"title":"18 V.S.A. 4201(16) (narcotic def)","url":"https://legislature.vermont.gov/statutes/section/18/084/04201","pinpoint":null,"publisher":"Vermont Legislature","type":"statute","primary":false,"official":true}],"history":[]}],"neighbors":[{"code":"MA","status":"legal"},{"code":"NH","status":"legal"},{"code":"NY","status":"legal"}],"laws":[{"citation":"18 V.S.A. 4201(10) (hallucinogenic drugs definition; schedules delegated to Dept. of Health rule under 4202)","title":"18 V.S.A. 4201(10) (hallucinogenic drugs definition; schedules delegated to Dept. of Health rule under 4202)","official_url":"https://legislature.vermont.gov/statutes/section/18/084/04201","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-10-08","text_hash":"c6f707ea9b84197e25a4ba74d480c3cee3434b10457aba33cf1b12c7ca367954"},{"citation":"Vermont Regulated Drug Rule (Dept. of Health), § 7.0 (Hallucinogenic Drugs; Tryptamines), under 18 V.S.A. §§ 4201–4202","title":null,"official_url":"https://www.healthvermont.gov/sites/default/files/documents/pdf/REG_regulated-drugs.pdf","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-06-19","text_hash":"011afd53c5b60e2b50eb111fa4acb70719ac3f5a748e454768f73124d2086d09"},{"citation":"Vermont Regulated Drug Rule Sec. 7.0 (18 V.S.A. Sec. 4201-4202; Sec. 4230-4237)","title":"Regulated Drug Rule Sec. 7.0 - Hallucinogenic Drugs; Synthetic Cannabinoids; Tryptamines; Cannabinimimetics; Mescaline Analogs; Dissociatives (named entry: 5-MAPB)","official_url":"https://www.healthvermont.gov/sites/default/files/documents/pdf/REG_regulated-drugs.pdf","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-07-20","text_hash":"dd18e4f4abf49a55e17735355462887e99d9e2b2ff449b1d85e960cd38795ab2"}]}